🔴 CalciMedica is trading 6.17% down in pre-market with no clear company-specific catalyst identified

CalciMedica is trading at $1.52, down 6.17%, in pre-market, with no clear company-specific catalyst identified for the October 5 decline.

• The latest SEC filings include a September 30 prospectus supplement and current report; their timing alone does not establish a cause.
• Major U.S. indices were down less than 0.5%, providing no strong broad-market explanation for the move.